Akèy › Twoub depresif majè › Washington
Etid klinik pou Twoub depresif majè nan Washington
21 etid pou Twoub depresif majè ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Aug 19, 2026 · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 10, 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jun 15, 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Sep 19, 2024 · NCT06005194Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.